
Genetic toxicity impurity testing services refer to the analysis and evaluation of potential impurities or substances that may cause genetic damage or mutations. These services are typically offered by specialized laboratories or research institutions to assess the safety and potential risks of pharmaceuticals, chemicals, or other substances in terms of their genotoxicity. The testing is conducted using various in vitro and in vivo assays to determine the potential genotoxic effects of impurities or substances, including their ability to induce mutations, chromosomal damage, or DNA damage. The results of these tests help in ensuring the safety and quality of products, as well as in regulatory compliance.
The global Genetic Toxicity Impurity Testing Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Genetic Toxicity Impurity Testing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Genetic Toxicity Impurity Testing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Genetic Toxicity Impurity Testing Services in Medical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Genetic Toxicity Impurity Testing Services include SGS, Inotiv, Charles River, Eurofins, SMITHERS, SUNNOVO, Agilent, Thermo Fisher Scientific and Waters, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Genetic Toxicity Impurity Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Toxicity Impurity Testing Services.
Report Scope
The Genetic Toxicity Impurity Testing Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetic Toxicity Impurity Testing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Toxicity Impurity Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
SGS
Inotiv
Charles River
Eurofins
SMITHERS
SUNNOVO
Agilent
Thermo Fisher Scientific
Waters
Beijing Protein nnovation
HED Group
CENTRE TESTING INTERNATIONAL (CTI)
PUYAN
XINYAO
Shimadzu
HEBEI LEAD TEST TECHNOLOGY CO.LTD
XIHUA
ICAS
STANDARD GROUP
LIIUPNARMATECH
HEZE PHARMACEUTICAL
Segment by Type
On-line Testing
Off-line Testing
Segment by Application
Medical
Bio-pharmaceuticals
Chemical
Agricultural
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Toxicity Impurity Testing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 On-line Testing
1.2.3 Off-line Testing
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical
1.3.3 Bio-pharmaceuticals
1.3.4 Chemical
1.3.5 Agricultural
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Genetic Toxicity Impurity Testing Services Growth Trends by Region
2.2.1 Global Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genetic Toxicity Impurity Testing Services Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Genetic Toxicity Impurity Testing Services Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Dynamics
2.3.1 Genetic Toxicity Impurity Testing Services Industry Trends
2.3.2 Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Drivers
2.3.3 Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Challenges
2.3.4 Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Toxicity Impurity Testing Services Players by Revenue
3.1.1 Global Top Genetic Toxicity Impurity Testing Services Players by Revenue (2019-2024)
3.1.2 Global Genetic Toxicity Impurity Testing Services Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Toxicity Impurity Testing Services Revenue
3.4 Global Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Toxicity Impurity Testing Services Revenue in 2023
3.5 Genetic Toxicity Impurity Testing Services Key Players Head office and Area Served
3.6 Key Players Genetic Toxicity Impurity Testing Services Product Solution and Service
3.7 Date of Enter into Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Toxicity Impurity Testing Services Breakdown Data by Type
4.1 Global Genetic Toxicity Impurity Testing Services Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Genetic Toxicity Impurity Testing Services Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Genetic Toxicity Impurity Testing Services Breakdown Data by Application
5.1 Global Genetic Toxicity Impurity Testing Services Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Genetic Toxicity Impurity Testing Services Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa Genetic Toxicity Impurity Testing Services Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SGS
11.1.1 SGS Company Detail
11.1.2 SGS Business Overview
11.1.3 SGS Genetic Toxicity Impurity Testing Services Introduction
11.1.4 SGS Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.1.5 SGS Recent Development
11.2 Inotiv
11.2.1 Inotiv Company Detail
11.2.2 Inotiv Business Overview
11.2.3 Inotiv Genetic Toxicity Impurity Testing Services Introduction
11.2.4 Inotiv Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.2.5 Inotiv Recent Development
11.3 Charles River
11.3.1 Charles River Company Detail
11.3.2 Charles River Business Overview
11.3.3 Charles River Genetic Toxicity Impurity Testing Services Introduction
11.3.4 Charles River Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.3.5 Charles River Recent Development
11.4 Eurofins
11.4.1 Eurofins Company Detail
11.4.2 Eurofins Business Overview
11.4.3 Eurofins Genetic Toxicity Impurity Testing Services Introduction
11.4.4 Eurofins Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.4.5 Eurofins Recent Development
11.5 SMITHERS
11.5.1 SMITHERS Company Detail
11.5.2 SMITHERS Business Overview
11.5.3 SMITHERS Genetic Toxicity Impurity Testing Services Introduction
11.5.4 SMITHERS Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.5.5 SMITHERS Recent Development
11.6 SUNNOVO
11.6.1 SUNNOVO Company Detail
11.6.2 SUNNOVO Business Overview
11.6.3 SUNNOVO Genetic Toxicity Impurity Testing Services Introduction
11.6.4 SUNNOVO Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.6.5 SUNNOVO Recent Development
11.7 Agilent
11.7.1 Agilent Company Detail
11.7.2 Agilent Business Overview
11.7.3 Agilent Genetic Toxicity Impurity Testing Services Introduction
11.7.4 Agilent Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.7.5 Agilent Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Genetic Toxicity Impurity Testing Services Introduction
11.8.4 Thermo Fisher Scientific Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Waters
11.9.1 Waters Company Detail
11.9.2 Waters Business Overview
11.9.3 Waters Genetic Toxicity Impurity Testing Services Introduction
11.9.4 Waters Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.9.5 Waters Recent Development
11.10 Beijing Protein nnovation
11.10.1 Beijing Protein nnovation Company Detail
11.10.2 Beijing Protein nnovation Business Overview
11.10.3 Beijing Protein nnovation Genetic Toxicity Impurity Testing Services Introduction
11.10.4 Beijing Protein nnovation Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.10.5 Beijing Protein nnovation Recent Development
11.11 HED Group
11.11.1 HED Group Company Detail
11.11.2 HED Group Business Overview
11.11.3 HED Group Genetic Toxicity Impurity Testing Services Introduction
11.11.4 HED Group Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.11.5 HED Group Recent Development
11.12 CENTRE TESTING INTERNATIONAL (CTI)
11.12.1 CENTRE TESTING INTERNATIONAL (CTI) Company Detail
11.12.2 CENTRE TESTING INTERNATIONAL (CTI) Business Overview
11.12.3 CENTRE TESTING INTERNATIONAL (CTI) Genetic Toxicity Impurity Testing Services Introduction
11.12.4 CENTRE TESTING INTERNATIONAL (CTI) Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.12.5 CENTRE TESTING INTERNATIONAL (CTI) Recent Development
11.13 PUYAN
11.13.1 PUYAN Company Detail
11.13.2 PUYAN Business Overview
11.13.3 PUYAN Genetic Toxicity Impurity Testing Services Introduction
11.13.4 PUYAN Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.13.5 PUYAN Recent Development
11.14 XINYAO
11.14.1 XINYAO Company Detail
11.14.2 XINYAO Business Overview
11.14.3 XINYAO Genetic Toxicity Impurity Testing Services Introduction
11.14.4 XINYAO Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.14.5 XINYAO Recent Development
11.15 Shimadzu
11.15.1 Shimadzu Company Detail
11.15.2 Shimadzu Business Overview
11.15.3 Shimadzu Genetic Toxicity Impurity Testing Services Introduction
11.15.4 Shimadzu Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.15.5 Shimadzu Recent Development
11.16 HEBEI LEAD TEST TECHNOLOGY CO.LTD
11.16.1 HEBEI LEAD TEST TECHNOLOGY CO.LTD Company Detail
11.16.2 HEBEI LEAD TEST TECHNOLOGY CO.LTD Business Overview
11.16.3 HEBEI LEAD TEST TECHNOLOGY CO.LTD Genetic Toxicity Impurity Testing Services Introduction
11.16.4 HEBEI LEAD TEST TECHNOLOGY CO.LTD Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.16.5 HEBEI LEAD TEST TECHNOLOGY CO.LTD Recent Development
11.17 XIHUA
11.17.1 XIHUA Company Detail
11.17.2 XIHUA Business Overview
11.17.3 XIHUA Genetic Toxicity Impurity Testing Services Introduction
11.17.4 XIHUA Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.17.5 XIHUA Recent Development
11.18 ICAS
11.18.1 ICAS Company Detail
11.18.2 ICAS Business Overview
11.18.3 ICAS Genetic Toxicity Impurity Testing Services Introduction
11.18.4 ICAS Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.18.5 ICAS Recent Development
11.19 STANDARD GROUP
11.19.1 STANDARD GROUP Company Detail
11.19.2 STANDARD GROUP Business Overview
11.19.3 STANDARD GROUP Genetic Toxicity Impurity Testing Services Introduction
11.19.4 STANDARD GROUP Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.19.5 STANDARD GROUP Recent Development
11.20 LIIUPNARMATECH
11.20.1 LIIUPNARMATECH Company Detail
11.20.2 LIIUPNARMATECH Business Overview
11.20.3 LIIUPNARMATECH Genetic Toxicity Impurity Testing Services Introduction
11.20.4 LIIUPNARMATECH Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.20.5 LIIUPNARMATECH Recent Development
11.21 HEZE PHARMACEUTICAL
11.21.1 HEZE PHARMACEUTICAL Company Detail
11.21.2 HEZE PHARMACEUTICAL Business Overview
11.21.3 HEZE PHARMACEUTICAL Genetic Toxicity Impurity Testing Services Introduction
11.21.4 HEZE PHARMACEUTICAL Revenue in Genetic Toxicity Impurity Testing Services Business (2019-2024)
11.21.5 HEZE PHARMACEUTICAL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
SGS
Inotiv
Charles River
Eurofins
SMITHERS
SUNNOVO
Agilent
Thermo Fisher Scientific
Waters
Beijing Protein nnovation
HED Group
CENTRE TESTING INTERNATIONAL (CTI)
PUYAN
XINYAO
Shimadzu
HEBEI LEAD TEST TECHNOLOGY CO.LTD
XIHUA
ICAS
STANDARD GROUP
LIIUPNARMATECH
HEZE PHARMACEUTICAL
Ìý
Ìý
*If Applicable.
